(19)
(11) EP 2 510 952 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
20.03.2019 Bulletin 2019/12

(45) Mention of the grant of the patent:
12.09.2018 Bulletin 2018/37

(21) Application number: 12165220.0

(22) Date of filing: 23.07.2006
(27) Previously filed application:
 23.07.2006 PCT/IL2006/000850
(51) International Patent Classification (IPC): 
A61K 51/12(2006.01)
 A61N 5/10(2006.01)

(54)

A radioactive surface source and a method for producing the same

Radioaktive Oberflächenquelle und Verfahren zu ihrer Herstellung

Source à surface radioactive et procédé de production correspondant

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

(30) Priority: 26.07.2005 US 702288 P

(43) Date of publication of application:
17.10.2012 Bulletin 2012/42

(62) Application number of the earlier application in accordance with Art. 76 EPC:
06766165.2 / 1909855

(73) Proprietor: Alpha TAU Medical Ltd.
6997801 Tel-Aviv (IL)

(72) Inventors:
  • Kelson, Itzhak
    63404 Tel Aviv (IL)
  • Schmidt, Michael
    53242 Givataim (IL)
  • Keisari, Yona
    Ramat Gan 52364 (IL)

(74) Representative: Dennemeyer & Associates S.A. 
Postfach 70 04 25
81304 München
81304 München (DE)


(56) References cited: : 
WO-A2-2004/096293
US-B1- 6 394 945
 US-A- 5 342 283
   
  • MEYER JULIUS M A ET AL: "Inhibition of neointimal proliferation with 188Re-labeled self-expanding nitinol stent in a sheep model.", RADIOLOGY DEC 2003 LNKD- PUBMED:14657319, vol. 229, no. 3, December 2003 (2003-12), pages 847-854, XP002682785, ISSN: 0033-8419
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).